Your Partner for Growth, Hybridan

Hybridan

Your Partner for Growth

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Equity Bottom-Up

<ul>
<li>The international provider of autonomy software, fully autonomous vehicles and mobile robotics platforms has been awarded a licence for the provision of Ground Handling Services at East Midlands Airport.</li>
<li>Aurrigo has obtained this licence specifically to support its partners in the roll-out and implementation of its autonomous aviation technologies.</li>
<li>This means the company is on the ground, providing one-to-one support during the roll-out of autonomous solutions, ensuring they are seamlessly integrated, compliant, and successful from the outset.</li>
</ul>


The international provider of autonomy software, fully autonomous vehicles and mobile robotics platforms has been awarded a licence for the provision of Ground Handling Services at East Midlands Airport.
Aurrigo has obtained this licence specifically to support its partners in the roll-out and implementation of its autonomous aviation technologies.
This means the company is on the ground, providing one-to-one support during the roll-out of autonomous solutions, ensuring they are seamlessly integrated, compliant, and successful from the outset.


<ul>
<li>Arecor Therapeutics 80.00p £29.26m (AREC.L) The biopharmaceutical Company focused on drug development and enhanced delivery in diabetes and other cardiometabolic diseases provided a business update for the 12 months ended 31 December 2025.</li>
<li>The Company continued focus on two core product areas: diabetes and oral delivery of peptides.</li>
<li>A codevelopment deal was signed in September 2025 with Sequel Med Tech to combine Arecor's ultra-concentrated, ultra-rapid-acting (500U/mL) insulin AT278 with Sequel's twist Automated Insulin Delivery (AID) system. </li>
</ul>


Arecor Therapeutics 80.00p £29.26m (AREC.L) The biopharmaceutical Company focused on drug development and enhanced delivery in diabetes and other cardiometabolic diseases provided a business update for the 12 months ended 31 December 2025.
The Company continued focus on two core product areas: diabetes and oral delivery of peptides.
A codevelopment deal was signed in September 2025 with Sequel Med Tech to combine Arecor's ultra-concentrated, ultra-rapid-acting (500U/mL) insulin AT278 with Sequel's twist Automated Insulin Delivery (AID) system. 


Hybridan Small Cap Feast: 9 February 2026

<ul><li>It’s been a tough few years for the beloved “value investor.” Never one to be lured into the small cap bubbles and eye watering share price movements we saw during the Covid biotech boom or more recently in 2025 with certain AI and bitcoin treasury companies commanding 100x revenue multiple or hefty *premiums* to NAV.</li><li>Amongst all the hysteria, value investors remained unwaveringly loyal to their investment criteria – underpinned by fundamentals of revenues, cash, traditional business models and conservative growth.</li><li> The phrase “patient capital” has long been out of fashion, giving rise to investor requirements of instant returns and liquidity.</li></ul>

It’s been a tough few years for the beloved “value investor.” Never one to be lured into the small cap bubbles and eye watering share price movements we saw during the Covid biotech boom or more recently in 2025 with certain AI and bitcoin treasury companies commanding 100x revenue multiple or hefty *premiums* to NAV.Amongst all the hysteria, value investors remained unwaveringly loyal to their investment criteria – underpinned by fundamentals of revenues, cash, traditional business models and conservative growth. The phrase “patient capital” has long been out of fashion, giving rise to investor requirements of instant returns and liquidity.

Aurrigo International PLC - Hybridan Monthly, 7 January 2026

<ul>
<li>The launch of the ‘Hub strategy’ programme will accelerate global commercialisation and licensing income from this manufacturer of autonomous airport vehicles.</li>
<li>The 'Hub strategy' is designed to align local partnerships, funding, operations and manufacturing with Aurrigo's proprietary technology platform.</li>
<li>The Hub partners and JVs will be at a local/subsidiary level to established regional ground operations and manufacturing capacity, to reduce risk, capital requirements and time to market. </li>
</ul>


The launch of the ‘Hub strategy’ programme will accelerate global commercialisation and licensing income from this manufacturer of autonomous airport vehicles.
The 'Hub strategy' is designed to align local partnerships, funding, operations and manufacturing with Aurrigo's proprietary technology platform.
The Hub partners and JVs will be at a local/subsidiary level to established regional ground operations and manufacturing capacity, to reduce risk, capital requirements and time to market. 


Cross Asset Strategy

<ul>
<li>12th May: Cobalt Holdings, a Company created primarily to purchase and hold physical cobalt, offering public equity investors pure-play direct exposure to the price of cobalt, confirmed its intention to raise approximately US$230m through its Global Offer and the Admission on to the Main Market in June 2025.</li>
<li>Glencore International AG and certain entities and affiliates managed by Anchorage Structured Commodities Advisor, have agreed to participate as cornerstone investors, agreeing to invest, in aggregate, an amount representing approximately 20.5% of the Shares to be offered pursuant to the Global Offer.</li>
<li>9th May: iFOREX Financial Trading, the fintech business with a proprietary online and mobile trading platform for multi-asset contracts for difference, announces that it has confirmed its intention to IPO onto the Main Market.</li>
</ul>


12th May: Cobalt Holdings, a Company created primarily to purchase and hold physical cobalt, offering public equity investors pure-play direct exposure to the price of cobalt, confirmed its intention to raise approximately US$230m through its Global Offer and the Admission on to the Main Market in June 2025.
Glencore International AG and certain entities and affiliates managed by Anchorage Structured Commodities Advisor, have agreed to participate as cornerstone investors, agreeing to invest, in aggregate, an amount representing approximately 20.5% of the Shares to be offered pursuant to the Global Offer.
9th May: iFOREX Financial Trading, the fintech business with a proprietary online and mobile trading platform for multi-asset contracts for difference, announces that it has confirmed its intention to IPO onto the Main Market.


United Kingdom

Aurrigo International is an international designer and developer of fully integrated smart airside solutions for the aviation industry, including automated vehicles, systems, and software. The company also designs and supplies advanced product and system solutions to automotive vehicle manufacturers. Aurrigo was formed in 1993 and is headquartered in Coventry, UK.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Aurrigo International (AURR LN)

Hybridan Small Cap Feast: 03 March 2026

Aurrigo has obtained this licence specifically to support its partners in the roll-out and implementation of its autonomous aviation technologies.

Hybridan

Hybridan Small Cap Feast: 9 February 2026

The biopharmaceutical Company focused on drug development and enhanced delivery in diabetes and other cardiometabolic diseases provided a business...

Hybridan

Aurrigo International PLC - Hybridan Monthly, 7 January 2026

It’s been a tough few years for the beloved “value investor.” Never one to be lured into the small cap bubbles and eye watering share price...

Hybridan

Friday Take Away: 12 December 2025

The launch of the ‘Hub strategy’ programme will accelerate global commercialisation and licensing income from this manufacturer of autonomous...

Hybridan

Hybridan Small Cap Feast: 21/05/2025

Glencore International AG and certain entities and affiliates managed by Anchorage Structured Commodities Advisor, have agreed to participate as...

Hybridan

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)